Obesity and Weight Management Research The primary focus of cagrilintide research has been its profound effects on body weight reduction [9] : Key Clinical Trial Data - Phase 2 ONWARDS 1 Design: 32-week, dose-ranging study in 706 adults with overweight/obesity Results (Cagrilintide monotherapy): [9] 0.3 mg weekly: -3.9% weight loss 0.6 mg weekly: -6.0% weight loss 1.2 mg weekly: -8.1% weight loss 2.4 mg weekly: -10.8% weight loss 4.5 mg weekly: -10.4% weight loss Mechanism: Weight loss attributed primarily to reduced energy intake (-535 kcal/day at 2.4 mg dose) rather than increased energy expenditure Research Implications: Cagrilintide provides a valuable research tool for investigating amylin receptor-mediated satiety pathways independent of GLP-1 signaling, offering insights into hormone-specific contributions to appetite regulation
M., Krishnan, B
Omega-3s support the skin's barrier function, enhancing its ability to retain moisture and reduce dryness and itchiness
Ferulic acid activates SIRT1-mediated ferroptosis signaling pathway to improve cognition dysfunction in Wilsons disease
Why Opioids Backfire With Repeated Use With repeated exposure, the nervous system adapts to opioids, leading to: Tolerance , requiring higher doses for the same effect (33,35) Dependence , with withdrawal symptoms when doses wear off (35) Opioid-induced hyperalgesia , a paradoxical increase in pain sensitivity (33,36) Rather than calming pain long term, opioids can sensitize the nervous system, making everyday stimuli feel more painful (33,36)
/product/29/5744914/1.jpg?1204)